Project Grant R03DE034037

Award Date 8/12/24
Completion Date 7/31/26
Dollars Obligated $498K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43205, USA
Similar Awards
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) program, provides $205,000 to The Regents of the University of California, San Francisco (UCSF) to study the effects of the oral microbiome on adverse outcomes in pediatric hematopoietic cell transplantation (HCT) recipients. The key objectives are to determine the relationship between dental treatment, the cariogenic oral microbiome,...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $315,000 to the University of California, Los Angeles (UCLA) to conduct a longitudinal study on the oral microbiome of HIV-exposed uninfected (HEU), HIV-positive, and HIV-unexposed uninfected children aged 3-4 in Western Kenya. The study will collect and analyze 1,080 oral swab samples over one year to understand how...
This Project Grant award of $198,000.00 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support a research study at The Pennsylvania State University (Penn State) to examine how one's background and socioeconomic factors shape oral microbial diversity and determine the extent to which these microbes contribute to oral health differences in the United States. The study will utilize 16S ribosomal...
This federal Project Grant award of $429,000.00 was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program. The grant supports research to determine the functional roles and mechanisms of the human microbiome and metabolome in the pathogenesis of oral squamous cell carcinoma (OSCC), a prevalent and lethal form of head and neck cancer. The research aims to 1) define OSCC-associated metagenomic and...
This federal Project Grant award in the amount of $469,830.00 was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The grant aims to identify oral bacterial species with anti-cancer properties and evaluate their potential for preventing or treating oral squamous cell carcinoma (OSCC). Specifically, the study will assess the effects of Streptococcus mitis and Haemophilus parainfluenzae on OSCC...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under CFDA program 93.121 Oral Diseases and Disorders Research, provides $409,403 to Branchpoint Biosciences Inc. for the development of a comprehensive qPCR-based oral microbiome profiling platform. The objectives are to: (1) determine key oral microbial targets by analyzing public metagenomic data, and (2) design and validate qPCR assays to accurately detect and quantify those targets....
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $473,632 to the University of Toledo to investigate the role of megakaryocytes (MEGs) in oral and craniofacial-related diseases. The goal is to determine how IL-17 receptor signaling in MEGs contributes to immune responses during oropharyngeal candidiasis (OPC) infections, which are a major complication for...
This Project Grant award, valued at $470,279.00 and awarded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research on the impact of bacterial oxidative stress responses on the ecology and pathogenicity of oral streptococci. The key goals are to identify and characterize the mechanisms by which oral streptococci, including the health-associated Streptococcus sanguinis and the caries-associated...
This $515,926 Project Grant awarded by the National Science Foundation (NSF) Engineering program (CFDA 47.041) will fund research to develop an in vitro gingival (gum) tissue system to study the role of microbial communities on oral health and disease. The 5-year project, beginning June 1, 2024, will be conducted by the University of Massachusetts Lowell's Office of Research Administration-Lowell. The key objectives are: (1) developing and validating a microphysiological system to study oral...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $656,315 to Temple University to study the impact of cyclic strain on the pathogenesis of oral microbes, particularly Candida albicans and denture-related microbiota. The goal is to mechanistically understand how biomaterial cyclic strain, driven by chewing forces, can influence the virulence and dysbiosis of oral...

This Project Grant award of $498,238 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support a longitudinal study investigating the oral microbiome in children undergoing hematopoietic cell transplants (HCT) at Nationwide Children's Hospital. The key objectives are to: 1) Define changes in the oral microbial community at the species level and relate these changes to the development and progression of oral mucositis and bloodstream infections in this high-risk pediatric population; and 2) Comprehensively characterize the bloodstream microbial profile in these children, and determine if the oral cavity is the likely source of bloodstream infection-associated microbes. A sub-award of an unspecified amount will be provided to The Ohio State University to conduct the microbiome analysis portion of the project. The results are expected to inform future preventive and therapeutic strategies to reduce the burden of oral complications in children undergoing HCT.

Generated 8/5/25, 3:41 AM